Samolyk-Kogaczewska Natalia, Sierko Ewa, Dziemianczyk-Pakiela Dorota, Nowaszewska Klaudia Beata, Lukasik Malgorzata, Reszec Joanna
Department of Radiotherapy, Comprehensive Cancer Center, 15-027 Bialystok, Poland.
Department of Oncology, Medical University of Bialystok, 15-027 Bialystok, Poland.
Cancers (Basel). 2020 Feb 22;12(2):511. doi: 10.3390/cancers12020511.
(1) Background: The novel hybrid of positron emission tomography/magnetic resonance (PET/MR) examination has been introduced to clinical practice. The aim of our study was to evaluate PET/MR usefulness in preoperative staging of head and neck cancer (HNC) patients (pts); (2) Methods: Thirty eight pts underwent both computed tomography (CT) and PET/MR examination, of whom 21 pts underwent surgical treatment as first-line therapy and were further included in the present study. Postsurgical tissue material was subjected to routine histopathological (HP) examination with additional evaluation of p16, human papillomavirus (HPV), Epstein-Barr virus (EBV) and Ki67 status. Agreement of clinical and pathological T staging, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) of CT and PET/MR in metastatic lymph nodes detection were defined. The verification of dependences between standardized uptake value (SUV value), tumor geometrical parameters, number of metastatic lymph nodes in PET/MR and CT, biochemical parameters, Ki67 index, p16, HPV and EBV status was made with statistical analysis of obtained results; (3) Results: PET/MR is characterized by better agreement in T staging, higher specificity, sensitivity, PPV and NPV of lymph nodes evaluation than CT imaging. Significant correlations were observed between SUVmax and maximal tumor diameter from PET/MR, between SUVmean and CT tumor volume, PET/MR tumor volume, maximal tumor diameter assessed in PET/MR. Other correlations were weak and insignificant; (4) Conclusions: Hybrid PET/MR imaging is useful in preoperative staging of HNC. Further studies are needed.
(1) 背景:正电子发射断层扫描/磁共振成像(PET/MR)这种新型混合检查已应用于临床实践。我们研究的目的是评估PET/MR在头颈部癌(HNC)患者术前分期中的作用;(2) 方法:38例患者接受了计算机断层扫描(CT)和PET/MR检查,其中21例患者接受手术作为一线治疗,并进一步纳入本研究。术后组织材料进行常规组织病理学(HP)检查,并额外评估p16、人乳头瘤病毒(HPV)、爱泼斯坦-巴尔病毒(EBV)和Ki67状态。定义了CT和PET/MR在转移性淋巴结检测中的临床和病理T分期的一致性、敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)。通过对所得结果进行统计分析,验证了PET/MR和CT中标准化摄取值(SUV值)、肿瘤几何参数、转移性淋巴结数量、生化参数、Ki67指数、p16、HPV和EBV状态之间的相关性;(3) 结果:与CT成像相比,PET/MR在T分期方面具有更好的一致性,在淋巴结评估方面具有更高的特异性、敏感性、PPV和NPV。在PET/MR的SUVmax与最大肿瘤直径之间、SUVmean与CT肿瘤体积、PET/MR肿瘤体积、PET/MR评估的最大肿瘤直径之间观察到显著相关性。其他相关性较弱且无统计学意义;(4) 结论:PET/MR混合成像在HNC术前分期中有用。需要进一步研究。